Roche Venture Fund

Roche Venture Fund is the corporate venture capital arm of Roche, a global leader in pharmaceuticals and diagnostics. Established in 2002, the fund focuses on investing in innovative life science companies, particularly in the fields of pharmaceuticals, diagnostics, and digital health. With an evergreen fund size of CHF 750 million, Roche Venture Fund aims to develop commercially successful enterprises by providing financial support and leveraging Roche’s extensive expertise.

The fund targets early-stage companies with innovative medicines, diagnostics, and technologies. In select cases, it invests alongside research and development collaborations with Roche or Genentech. The fund’s investment strategy is global, forward-looking, and willing to take risks on innovations with high potential reward.